Financials

News Ideas Minds Technicals Forecast

SABS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of SAB Biotherapeutics, Inc.

Total assets of SABS for Q1 24 is 71.37 M USD, 14.97% less than the previous Q4 23. And total liabilities decreased by 30.37% in Q1 24 to 18.55 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—